Sign in Register

Drug class

Urinary Alkalinizers

Urinary alkalinizers are a therapeutic class of systemic agents—predominantly composed of citrate salts such as potassium citrate or sodium bicarbonate—that reduce the acidity of urine. Read more about Urinary Alkalinizers

37 drugs in this class 23 manufacturers

Related classes & indications

Iron Chelating AgentsOther therapeutic classes · 45 prescription drugs Phosphodiesterase-4 (PDE4) inhibitorsOther therapeutic classes · 20 prescription drugs

Showing 19–27 of 37 drugs

Sort

PHOSPHO-TRIN 250 NEUTRAL (sodium phosphate,dibasic/pot phos,monob/sod phosphate mono)

PHOSPHATES · HYPOPHOSPHATEMIA

PATRIN PHARMA

PHOSPHOROUS (sodium phosphate/potassium phosphates, monobasic and dibasic)

PHOSPHATES · HYPOPHOSPHATEMIA

BROOKFIELD PHAR

PHOSPHOROUS (sodium phosphate,dibasic/pot phos,monob/sod phosphate mono)

PHOSPHATES · HYPOPHOSPHATEMIA

BROOKFIELD PHAR

UROCIT-K 10 (potassium citrate)

BICARBONATES · RENAL TUBULAR ACIDOSIS ·+4

Mission Pharmacal

K-PHOS NO 2 (sodium phosphate,monobasic/potassium phosphate,monobasic)

PHOSPHATES

BEACH PRODUCTS

UROCIT-K 15 (potassium citrate)

BICARBONATES · RENAL TUBULAR ACIDOSIS ·+4

Mission Pharmacal

POTASSIUM CITRATE ER (potassium citrate)

BICARBONATES · RENAL TUBULAR ACIDOSIS ·+4

CAMBER PHARMACE

POTASSIUM CITRATE ER (potassium citrate)

BICARBONATES · RENAL TUBULAR ACIDOSIS ·+4

BIOCOMP PHARMA,

POTASSIUM CITRATE ER (potassium citrate)

BICARBONATES · RENAL TUBULAR ACIDOSIS ·+4

GSMS, INC.

Filter & compare in the drug finder → Opens the drug finder with Urinary Alkalinizers preselected. Add indication or manufacturer filters there.

About Urinary Alkalinizers.

Urinary alkalinizers are a therapeutic class of systemic agents—predominantly composed of citrate salts such as potassium citrate or sodium bicarbonate—that reduce the acidity of urine.

Following systemic absorption and metabolic conversion, these agents promote base excretion by the kidneys, raising urinary pH and augmenting urinary citrate levels to inhibit crystalline precipitation and improve the solubility of poorly soluble weak acids.

Clinically, they are primary therapies in nephrology and urology for preventing and managing recurrent nephrolithiasis, including uric acid, cystine, and hypocitraturic calcium oxalate stones, as well as managing renal tubular acidosis.

They are also utilized in clinical toxicology and oncology to enhance the renal elimination of weak-acid toxins, such as salicylates, and to prevent crystal nephropathy during high-dose methotrexate therapy.

fda.gov
Urinary alkalinizers are a therapeutic class of systemic agents—predominantly composed of citrate salts such as potassium citrate or sodium bicarbonate—that reduce the acidity of urine Following systemic absorption and metabolic conversion, these agents promote base excretion by the kidneys, raising urinary pH and augmenting urinary citrate levels to inhibit crystalline precipitation and improve the solubility of poorly soluble weak acids Clinically, they are primary therapies in nephrology and ...
rxlist.com
Urinary alkalinizers are a therapeutic class of systemic agents—predominantly composed of citrate salts such as potassium citrate or sodium bicarbonate—that reduce the acidity of urine Following systemic absorption and metabolic conversion, these agents promote base excretion by the kidneys, raising urinary pH and augmenting urinary citrate levels to inhibit crystalline precipitation and improve the solubility of poorly soluble weak acids Clinically, they are primary therapies in nephrology and ...
nih.gov
Urinary alkalinizers are a therapeutic class of systemic agents—predominantly composed of citrate salts such as potassium citrate or sodium bicarbonate—that reduce the acidity of urine Following systemic absorption and metabolic conversion, these agents promote base excretion by the kidneys, raising urinary pH and augmenting urinary citrate levels to inhibit crystalline precipitation and improve the solubility of poorly soluble weak acids
nih.gov
They are also utilized in clinical toxicology and oncology to enhance the renal elimination of weak-acid toxins, such as salicylates, and to prevent crystal nephropathy during high-dose methotrexate therapy
nih.gov
They are also utilized in clinical toxicology and oncology to enhance the renal elimination of weak-acid toxins, such as salicylates, and to prevent crystal nephropathy during high-dose methotrexate therapy